Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001070081-17-000078
Filing Date
2017-04-28
Accepted
2017-04-27 19:14:05
Documents
5
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2017proxynotice.htm DEFA14A 26201
2 a2017proxynotice001.jpg GRAPHIC 79913
3 a2017proxynotice002.jpg GRAPHIC 117171
4 a2017proxynotice003.jpg GRAPHIC 30977
5 a2017proxynotice004.jpg GRAPHIC 6157
  Complete submission text file 0001070081-17-000078.txt   331015
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35969 | Film No.: 17791019
SIC: 2834 Pharmaceutical Preparations